Literature DB >> 3418336

Inhibition or enhancement of kindling evolution by antiepileptics.

M Schmutz1, K Klebs, V Baltzer.   

Abstract

The influence of antiepileptics on the evolution of rat amygdaloid kindling was studied. Under placebo conditions clonic convulsions and a spike-wave EEG pattern developed. Diazepam, clonazepam, clobazam and phenobarbital were most effective in suppressing the evolution of kindling; the effects of valproate sodium, ethosuximide and acetazolamide were somewhat less pronounced in this respect. Carbamazepine, oxcarbazepine and phenytoin, on the other hand, enhanced kindling development, i.e. the increase in duration of after-discharge was faster than in the placebo group. The results indicate that under the above experimental conditions drugs with no anti-absence component can be distinguished from those with an anti-absence component. The mechanism of action underlying the observed effects is not yet known; the hypothesis that under special conditions protective inhibitory neuronal activity can develop to absence type seizures is proposed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418336     DOI: 10.1007/BF01243423

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  25 in total

1.  NEUROLOGY GRAND ROUNDS: PETIT MAL, MYOCLONIC AND AKINETIC SEIZURES, INFANTILE SPASMS.

Authors:  R S PAINE
Journal:  Clin Proc Child Hosp Dist Columbia       Date:  1965-03

2.  Tridione in the treatment of epilepsy.

Authors:  W G LENNOX
Journal:  J Am Med Assoc       Date:  1947-05-10

3.  Anticonvulsant drug mechanisms of action.

Authors:  R L Macdonald; M J McLean; J H Skerritt
Journal:  Fed Proc       Date:  1985-07

4.  [Kindling effect by amygdaloid stimulation in the cat and rat: neurophysiologic and neuropharmacologic approach].

Authors:  T Tanaka; H Lange
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1975 Jan-Mar

Review 5.  Relevance of kindling and related processes to human epileptogenesis.

Authors:  M Schmutz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1987       Impact factor: 5.067

6.  Increased glucose metabolism during long-duration recurrent inhibition of hippocampal pyramidal cells.

Authors:  R F Ackermann; D M Finch; T L Babb; J Engel
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

7.  Effects of phenytoin on amygdaloid kindled seizures in the rat.

Authors:  A L Ehle
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-01

8.  Exacerbation of seizures in children by carbamazepine.

Authors:  O C Snead; L C Hosey
Journal:  N Engl J Med       Date:  1985-10-10       Impact factor: 91.245

9.  A pharmacological study in the kindling model of epilepsy.

Authors:  T E Albertson; R M Joy; L G Stark
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

10.  Blockade of "antiabsence" activity of sodium valproate by THIP in rats with petit mal-like seizures. Comparison with ethosuximide.

Authors:  M Vergnes; C Marescaux; G Micheletti; L Rumbach; J M Warter
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more
  11 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Evaluation of the anticonvulsant and biochemical activity of CGS 8216 and CGS 9896 in animal models.

Authors:  R Bernasconi; C Marescaux; M Vergnes; K Klebs; M Klein; P Martin; C Portet; L Maitre; M Schmutz
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice.

Authors:  Seema Jain; Nidhi Bharal; Sonam Khurana; Pramod Kumari Mediratta; Krishna Kishore Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

4.  Ethosuximide and phenytoin dose-dependently attenuate acute nonconvulsive seizures after traumatic brain injury in rats.

Authors:  Andrea Mountney; Deborah A Shear; Brittney Potter; Sean R Marcsisin; Jason Sousa; Victor Melendez; Frank C Tortella; Xi-Chun M Lu
Journal:  J Neurotrauma       Date:  2013-10-18       Impact factor: 5.269

Review 5.  Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.

Authors:  Bryan L Clossen; Doodipala Samba Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-05       Impact factor: 5.187

6.  Baclofen prevents rapid amygdala kindling in adult rats.

Authors:  J N Wurpel
Journal:  Experientia       Date:  1994-05-15

Review 7.  Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

Authors:  S M Grant; D Faulds
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

8.  Blockade of GABAB receptors accelerates amygdala kindling development.

Authors:  G Karlsson; K Klebs; T Hafner; M Schmutz; H R Olpe
Journal:  Experientia       Date:  1992-08-15

9.  The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.

Authors:  M Schmutz; C Portet; A Jeker; K Klebs; A Vassout; H Allgeier; R Heckendorn; G E Fagg; H R Olpe; H van Riezen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.